B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo therapy aims to beat back childhood blood cancers
Disease control OngoingThis large phase 3 study tests whether adding the drug blinatumomab to standard chemotherapy can improve outcomes for children and young adults with newly diagnosed B-cell acute lymphoblastic leukemia or lymphoma, including those with Down syndrome. The trial enrolls over 6,700 p…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New combo therapy shows promise for older blood cancer patients
Disease control OngoingThis study compares a new combination of a targeted drug (inotuzumab) plus chemotherapy against standard chemotherapy alone in older adults with B-cell acute lymphoblastic leukemia or lymphoma. The targeted drug attaches to cancer cells and delivers a toxin to kill them. The goal…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC